XML 162 R128.htm IDEA: XBRL DOCUMENT v3.10.0.1
Markel Corporation (Parent Company Only) Financial Information (Schedule Of Condensed Statements Of Income And Comprehensive Income) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]                              
Net investment income                         $ 434,215 $ 405,709 $ 373,230
Change in fair value of equity securities [1]                         (425,622) (44,888) 16,791
Net investment gains (losses)                         (437,596) [2] (5,303) [3] 65,147 [4]
Total Operating Revenues $ 1,042,852 $ 2,235,949 $ 1,987,013 $ 1,575,471 $ 1,662,267 $ 1,506,148 $ 1,481,493 $ 1,411,751 $ 1,428,625 $ 1,431,282 $ 1,375,937 $ 1,376,182 6,841,285 6,061,659 5,612,026
Services and other expenses                         474,924 [5] 458,621 [6] 416,141 [7]
Interest expense                         154,212 132,451 129,896
Net foreign exchange gains (losses)                         106,598 3,140 (1,253)
Loss on early extinguishment of debt                         0 0 44,100
Total operating expenses                         6,801,526 5,845,053 4,806,857
Income tax benefit                         122,498 (313,463) 169,477
Net Income (Loss) to Shareholders (751,543) [8] 409,438 [8] 278,231 [8] (64,306) [8] 434,881 [8] (259,141) [8] 149,660 [8] 69,869 [8] 132,726 [8] 83,796 [8] 78,797 [8] 160,370 [8] (128,180) [9] 395,269 [9] 455,689 [9]
Net holding gains (losses) arising during the period                         (241,325) 787,339 275,661
Reclassification adjustments for net gains included in net income to shareholders                         7,849 (24,296) (33,528)
Change in net unrealized gains on available-for-sale investments, net of taxes                         (233,476) 763,043 242,168
Change in foreign currency translation adjustments, net of taxes                         (16,495) 10,449 (11,704)
Total Other Comprehensive Income (Loss)                         (247,630) 779,751 211,364
Comprehensive Income (Loss) to Shareholders $ (680,373) $ 315,106 $ 164,336 $ (174,839) $ 629,247 $ (19,869) $ 342,357 $ 223,239 $ (29,050) $ 89,161 $ 209,942 $ 396,994 (375,770) 1,174,974 667,047
Parent Company [Member]                              
Condensed Financial Statements, Captions [Line Items]                              
Net investment income                         32,631 21,076 9,561
Dividends on common stock of consolidated subsidiaries                         749,171 895,920 349,622
Marketable Securities, Realized Gain (Loss)                         (3,341) 3,383 1,068
Change in fair value of equity securities [10]                         (110,356) 0 0
Net investment gains (losses)                         (113,697) 3,383 1,068
Total Operating Revenues                         668,105 920,379 360,251
Services and other expenses                         6,532 11,708 13,076
Interest expense                         145,681 122,151 116,013
Net foreign exchange gains (losses)                         (3,391) 0 0
Loss on early extinguishment of debt                         0 0 44,100
Total operating expenses                         148,822 133,859 173,189
Income before equity in undistributed earnings of consolidated subsidiaries and income taxes                         519,283 786,520 187,062
Equity in undistributed earnings of consolidated subsidiaries                         (696,045) (469,365) 196,615
Income tax benefit                         (48,582) (78,114) (72,012)
Net Income (Loss) to Shareholders                         (128,180) 395,269 455,689
Net holding gains (losses) arising during the period                         (1,492) 52,277 37,045
Consolidated subsidiaries' net holding gains (losses) arising during the period                         (239,833) 735,062 238,616
Reclassification adjustments for net gains included in net income to shareholders                         2,564 (1,513) (523)
Consolidated subsidiaries' reclassification adjustments for net gains included in net income to shareholders                         5,285 (22,783) (32,970)
Change in net unrealized gains on available-for-sale investments, net of taxes                         (233,476) 763,043 242,168
Change in foreign currency translation adjustments, net of taxes                         0 (2,260) (1,326)
Consolidated subsidiaries' change in foreign currency translation adjustments, net of taxes                         (16,455) 12,663 (10,384)
Consolidated subsidiaries' change in net actuarial pension loss, net of taxes                         2,341 6,259 (19,100)
Total Other Comprehensive Income (Loss)                         (247,590) 779,705 211,358
Comprehensive Income (Loss) to Shareholders                         $ (375,770) $ 1,174,974 $ 667,047
[1] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 1. Prior to adopting ASU No. 2016-01, the Company recorded certain investments in equity securities at estimated fair value with changes in fair value recorded in net income.
[2] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, the change in fair value of equity securities is no longer recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net investment losses within net income. Prior periods have not been restated to conform to the current presentation. See note 1.
[3] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, the change in fair value of equity securities is no longer recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net investment losses within net income. Prior periods have not been restated to conform to the current presentation. See note 1.
[4] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, the change in fair value of equity securities is no longer recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net investment gains within net income. Prior periods have not been restated to conform to the current presentation. See note 1.
[5] Products expenses and services and other expenses for the Markel Ventures segment include depreciation expense of $52.2 million for the year ended December 31, 2018.
[6] Products expenses and services and other expenses for the Markel Ventures segment include depreciation expense of $41.7 million for the year ended December 31, 2017.
[7] Products expenses and services and other expenses for the Markel Ventures segment include depreciation expense of $35.5 million for the year ended December 31, 2016.
[8] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, the change in fair value of equity securities is no longer recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 1.
[9] Effective January 1, 2018, the Company adopted ASU No. 2016-01 and equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income, rather, changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 1.
[10] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 1.